Kanabo Research

Kanabo Research Overview

  • Founded
  • 2016
  • Status
  • Private
  • Employees
  • 12
  • Latest Deal Type
  • Reverse Merger
  • (Announced)
  • Investors
  • 1

Kanabo Research General Information


Operator of a research and development company intended to develop formulations of medical Cannabis. The company's drug development includes five initial formulations of medical Cannabis extracts for treating Central Nervous System disorders, enabling medical researchers to find a natural alternative to chemical ingredients for treating diseases.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Other Industries
Drug Discovery
Primary Office
  • 2 Kaplan Street
  • Tel Aviv 46578
  • Israel

Kanabo Research Timeline

Date FoundedFinancing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Kanabo Research Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Reverse Merger 11-Mar-2020 00000 Announced Generating Revenue
3. Early Stage VC 20-Dec-2018 00000 00000 Completed Startup
2. Seed Round 16-Mar-2017 Completed Startup
1. Angel (individual) 01-Mar-2017 Cancelled Startup

Kanabo Research Executive Team (4)

Name Title Board Seat Contact Info
Avihu Tamir Co-Founder, Chief Executive Officer & Board Member
Meirav Horn Chief Financial Officer
David Sack Co-Founder & Chief Marketing Officer
Rom Lakritz Chief Operating Officer

Kanabo Research Board Members (3)

Name Representing Role Since
Avihu Tamir Kanabo Research Co-Founder, Chief Executive Officer & Board Member 000 0000
David Tsur Self Board Member 000 0000
Uziel Danino Self Chairman 000 0000

Kanabo Research Investors (1)

To view Kanabo Research‘s full investor history, request access »
Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Entourage Effect Capital PE/Buyout Minority 000 0000 000000 0

Ready to get started?

Request a free trial